Back to search

Plusultra Pharma Uk Ltd

12972395

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

149 WOODSTOCK ROAD, OXFORD, OX2 7NA
Incorporated 23/10/2020

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 23/10/2025

Due 06/11/2026

On track

Industry

21100
Manufacture of basic pharmaceutical products
21200
Manufacture of pharmaceutical preparations
46460
Wholesale of pharmaceutical goods
72190
Other research and experimental development on natural sciences and engineering

Officers

Mr Takahiro Yamasaki

director · Since 23/10/2020

COMPANY DIRECTOR

JAPANESE · GERMANY · Age 58

Persons with Significant Control

Mr Jin Shiomura

Appoint directors

Japanese · Japan · Age 71

149, Woodstock Road, Oxford, OX2 7NA

Notified 23/10/2020

Ms Aya Iwano

25–50% votes

Japanese · Japan · Age 40

149, Woodstock Road, Oxford, OX2 7NA

Notified 08/11/2021

Ms Kai Shiomura

25–50% votes

Japanese · Australia · Age 42

149, Woodstock Road, Oxford, OX2 7NA

Notified 08/11/2021

Jaksap Pty Ltd

25–50% shares

Suite 2204, Level 2, Southport Central Tower 2, 5 Lawson Street, Qld, 0004215

Reg: 656162397 · Australian Business Register · Australian Proprietary Company

Notified 09/11/2021

Former PSCs

Plusultra Pharma Gmbh

Ceased 23/10/2020

Mr Takahiro Yamasaki

Ceased 23/10/2020

CompanyRankvs 218+ SIC 21100 peers
71

Financial strength84th percentile among SIC peers · 21/25
Employees84th percentile among SIC peers · 13/15
LiquidityCurrent ratio 1.79× · 16/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£369k

Balance sheet strength

Cash

£391k

Cash in the bank

Net Current Assets

£368k

Working capital

Current Assets

£831k

Current Liabilities

£463k

Fixed Assets

£2k

Debtors

£440k

5avg. employees+1

Balance Sheet

Assets less current liabilities£369k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20241.79-£148k
20236.40-£78k
202212.20+£198k
202114.52

Derived from filed accounts. Not audited figures.